 |
 |

Adenocarcinoma of the PancreasA Ten-Year Experience
Ronald W. Knight, MD;
James P. Scarborough, MD;
J. Catlin Goss, MD
Arch Surg. 1978;113(12):1401-1404.
Abstract
The experience with proved pancreatic adenocarcinoma in Portland, Ore, for 1965 through 1975 is compared with the decade 1955 through 1965. Little difference is found in time of diagnosis, incidence of resection vs bypass or laparotomy, types of resection, and overall survival. However, operative mortality improved and survival after total pancreatectomy improved from seven to 23 months. Whipple resections leave residual pancreatic tumor in one third of patients. Combining fluorouracil and radiotherapy significantly increases survival after palliative bypass (15 months vs 7.4 months, P <.02). Based on low operative mortality, improved survival, and avoidance of residual tumor, use of total pancreatectomy as the resection of choice is recommended.
(Arch Surg 113:1401-1404, 1978)
Author Affiliations
From the Departments of Surgery, St Vincent Hospital and Medical Center, Portland, Ore (Drs Knight and Goss) and the University of Oregon Health Sciences Center, Portland, Ore (Dr Scarborough).
Footnotes
Accepted for publication April 6, 1978.
Reprint requests to Division of Cardiopulmonary Surgery, University of Oregon Health Sciences Center, 3181 S W Sam Jackson Park Rd, Portland, OR 97201 (Dr Knight).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Observations on the Developmental Patterns and the Consequences of Pancreatic Exocrine Adenocarcinoma: Findings of 154 Autopsies
Mao et al.
Arch Surg 1995;130:125-134.
ABSTRACT
|